CD30(Ki-1)
Methodology
Immunohistochemistry (IHC)
Test Description and clinical significance
Disease:
Immunoblastic B cell or anaplastic T cell malignant lymphomas
CD30, also known as TNFRSF8, is a cell membrane protein of the tumor necrosis factor receptor family and tumor marker. CD30 (Ki-1) is a marker of lymphocyte activation and is characteristic of immunoblastic B cell or anaplastic T cell malignant lymphomas
Specimen Requirements
Collection:
FFPE/un-stained slides/Fresh tissue in formalin
Stability:
Room temperature
Unacceptable Conditions:
Unlabeled specimen/specimen left unfixed
for extended periods
Storage & Transport
Room Temperature
CPT(s)
88342 if intial single stain or 88341 for each additional stain. CD30
New York Approved
NO
TAT
1 Day
*The CPT codes provided are for informational purposes only and are based on AMA guidelines The billing party is solely responsible for correct CPT coding.
